Insulet (PODD) Stock: Buy, Sell, or Hold?
PODD - Insulet Corporation
$131.69
0.90 (0.69%)
▲
5d:
-3.26%
30d:
-11.1%
90d:
-17.58%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When PODD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: PODD shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: PODD shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$327.66
Based on 11.3% avg growth
INTRINSIC VALUE TODAY
$203.45
35.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PODD is currently trading at $131.69, which is considered oversold relative to its 30-day fair value range of $134.14 to $145.69. From a valuation perspective, the stock is trading at a discount (Forward PE: 17.1) compared to its historical average (28.0). Remarkably, the market is currently pricing in an annual earnings decline of 15.2% over the next few years. This pessimistic expectation contrasts with the company's recent 328.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PODD is in a downtrend. The price is currently testing key support at $128.01. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $171.91 (+30.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PODD is in a downtrend. The price is currently testing key support at $128.01. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $171.91 (+30.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$134.14 -
$145.69
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
Protect Your Profits
Holding PODD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (49/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 30.5% below Wall St target ($171.91)
- WARNING: Composite score 51/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$134.14 -
$145.69
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$128.01
Resistance Level
$142.04
Current Trend
Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.07
Wall Street Target
$171.91
(+30.5%)
Revenue Growth (YoY)
23.5%
Earnings Growth (YoY)
328.6%
Profit Margin
12.3%
Valuation Discount vs History
-15.2% cheaper
PE vs Historical
17.1 vs 28.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-15.2%
(market-implied from PE analysis)
1-Year Target
$118.52
(-10%)
2-Year Target
$106.67
(-19%)
3-Year Target
$96.00
(-27%)
3-Yr Target (if PE normalizes)
(PE: 17→28)
$157.48
(+20%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 18.6%)
$262.84
(+100%)
Base:
(SPY PE: 17.1, Growth: 18.6%)
$219.92
(+67%)
Bear:
(PE: 14.5, Growth: 18.6%)
$186.94
(+42%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 24.58 | Current EPS (TTM): $5.32
Bull Case
$208.64
(+58%)
Analyst growth 45.0%, PE expands to 27.0
Base Case
$189.68
(+44%)
Market implied 45.0%, PE stable at 24.6
Bear Case
$88.94
(-33%)
Severe decline -20.0%, PE contracts to 20.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 17.1 to 28.0
Stabilization Target:
$216.03
(+64.0%)
PE Expansion Potential:
+64.0%
Share & Embed Analysis
Last updated: October 03, 2026 9:15 AM ET
Data refreshes hourly during market hours. Next update: 10:15 AM
Data refreshes hourly during market hours. Next update: 10:15 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PODD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$369 | 69 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 47 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 58 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 38 SELL |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$83 | 60 BUY |
Advanced PODD Option Strategies
Professional options setups generated by AI based on today's PODD price and gamma walls.
